Cargando…
Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway
BACKGROUND: Long non-coding RNA (lncRNA) UCA1 is an oncogene in breast cancer. The purpose of this study was to investigate the role of UCA1 in tamoxifen resistance of estrogen receptor positive breast cancer cells. MATERIAL/METHODS: Tamoxifen sensitive MCF-7 cells were transfected for UCA1 overexpr...
Autores principales: | Wu, Chihua, Luo, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077288/ https://www.ncbi.nlm.nih.gov/pubmed/27765938 http://dx.doi.org/10.12659/MSM.900689 |
Ejemplares similares
-
LncRNA UCA1 in anti-cancer drug resistance
por: Wang, Haohao, et al.
Publicado: (2017) -
Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2017) -
lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion
por: Zha, Zhuqing, et al.
Publicado: (2020) -
The prognostic value and mechanisms of lncRNA UCA1 in human cancer
por: Yao, Fei, et al.
Publicado: (2019) -
Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer
por: Jiang, Yiyan, et al.
Publicado: (2022)